Epithelial makers (KRT18, KRT19, KRT17, KRT7, and CLDN4) were also highly expressed (59), indicating that M2 may be derived from transdifferentiation of epithelial cells in the tumor (60, 61). The gene discussed is CLDN4; the disease is neoplasm.